Salt Lake City, UTNCT04511806Now EnrollingIRB Ready

Pediatric Cancer Clinical Trial in Salt Lake City, UT

Access cutting-edge pediatric cancer treatment through this clinical trial at a research site in Salt Lake City. Study-provided care at no cost to qualified participants.

Sponsored by Emory University

Quick Self-Assessment

See if you qualify for this Salt Lake City location

Preparing your pre-screening questions…

Expert Care in Salt Lake City

Access pediatric cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pediatric cancer treatment provided free

Apply for This Salt Lake City Location

Check if you qualify for this pediatric cancer clinical trial in Salt Lake City, UT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Salt Lake City

    Convenient for UT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Salt Lake City site if eligible
  4. 4Begin participation

About This Pediatric Cancer Study in Salt Lake City

The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).

Sponsor: Emory University

Who Can Participate

Inclusion Criteria

Primary Subjects must meet all of the below criteria to be eligible for enrollment:
Be less than 21 years of age at the time of enrollment
Have a diagnosis of a specific CPS, whether they have had cancer or not
Based on clinical laboratory testing demonstrating a Pathogenic or Likely Pathogenic germline variant and/or
Based on well-established clinical diagnostic criteria and/or
Based on high clinical suspicion of a specific CPS with clinical laboratory testing demonstrating a variant of uncertain significance (VUS) Affected Parents must meet all of the following criteria to be eligible for enrollment:
Be the biologic parent of a Primary Subject and
Carry a diagnosis (or obligate diagnosis) of the familial CPS Adult Affected Siblings must meet all of the following criteria to be eligible for enrollment:
Be the biologic sibling of a Primary Subject and
Carry a diagnosis (or obligate diagnosis) of the familial CPS Unaffected Parents and Siblings must meet all of the following criteria to be eligible for enrollment
Be the biologic parent or sibling of a Primary Subject and
Not carry a diagnosis (or obligate diagnosis) of the familial CPS Affected Family Members must meet all of the following criteria to be eligible for enrollment: 1\. Carry a diagnosis of (or obligate diagnosis of) the familial CPS. Documentation is requested but not required. More than one child from a Primary Family Unit may be a Primary Subject. An Unaffected Sibling may be reclassified as a Primary Subject if diagnosed with a CPS during childhood.

Exclusion Criteria

Individuals with a strong personal or family history of cancer without a genetic or clinical diagnosis of a specific CPS are not eligible for enrollment.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Salt Lake City?

Yes, this clinical trial (NCT04511806) has an active research site in Salt Lake City, UT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pediatric Cancer Treatment Options in Salt Lake City, UT

If you're searching for pediatric cancer treatment options in Salt Lake City, UT, this clinical trial (NCT04511806) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Salt Lake City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pediatric cancer clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Salt Lake City, UT

See all pulmonary embolism clinical trials recruiting in Salt Lake City — not just this study.

Browse Pulmonary Embolism Trials in Salt Lake City

Ready to Join in Salt Lake City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Salt Lake City, UT